Data as of 3:59pm ET
| -0.03 / -2.94%|
The 1 analysts offering 12-month price forecasts for Acasti Pharma Inc have a median target of 3.63, with a high estimate of 3.63 and a low estimate of 3.63. The median estimate represents a +266.99% increase from the last price of 0.99.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.